Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER_GOV × Platinum × Clear all

Phase

Status

Sponsor Class

OTHER 56 NIH 21 NETWORK 18 INDUSTRY 4 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Capecitabine 24 Cisplatin 21 tislelizumab 20 apatinib 20 Gemcitabine 20 Oxaliplatin 19 Paclitaxel 18 Irinotecan 17 Carboplatin 16 Docetaxel 15 Bevacizumab 13 Fluorouracil 12 Drug Therapy 11 pembrolizumab 10 camrelizumab 10 Cyclophosphamide 10 Radiation 9 Vinorelbine 8 S 1 (combination) 8 Rituximab 7 Erlotinib Hydrochloride 7 Cetuximab 7 Leucovorin 6 Albumin-Bound Paclitaxel 6 toripalimab 5 pyrotinib 5 fludarabine 5 Nivolumab 5 Injections 5 Everolimus 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01669226 2016-12-19

AICE

Shanghai Gynecologic Oncology Group

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡